Table 1.
Surface maker | Specific transcription factors | Common function | |||||||
---|---|---|---|---|---|---|---|---|---|
DC subset | Murine | Human | Antigen presentation and cytokine production | Downstream effect | |||||
cDC | cDC1 | CD11chi, MHC-II+, CD45RA−, Siglec H−, PCDA-1− |
XCR1+, Clec9A+, DEC205+ |
CD8α+ (lymphoid tissues) |
HLA-DR+, CD11c+, CD123− |
XCR1+, CD141+, Clec9A+ |
Irf8, Id2, Batf3 |
Direct and cross-presentation IL-12, IL-6, Type III IFN |
CD8+ T cell activation Th1 activation |
CD103+ (non-lymphoid tissues) | |||||||||
cDC2 | Sirpα+, CD11b+ | Esamhi, CD4+, Clec4a4+ (lymphoid tissues) |
Sirpα+, CD1c+, CD301+ | Irf4, Notch2, Klf4 |
Direct presentation IL-6, TNF-α IL-23 (intestinal and lung) |
Th2 and Th17 activation | |||
Esamlo, Clec12A+, CD103+/− (non-lymphoid tissues) | |||||||||
pDCs | CD11cint, MHC-II−, CD45R+, CD45RA+, Siglec H+, PCDA-1+ |
CD11clo, CD123+, CD45RA+, BDCA2+, BDCA4+ | E2-2, Irf8, Bcl11a, Runx2, SpiB | Type I, Type III interferons IL-12, IL-6 |
Antiviral immunity | ||||
moDCs | CD11c+, MHC-II+, CD11b+ | CD11c+, HLA-DR+, CD14+, BDCA1+, FcεRI+, CD206+ | Klf4, Irf8 | TNF-α, IL-12, IL-23, iNOS | Th1 and Th17 response | ||||
Langerhans cells | EpCAMhi, MHC-II+, CD11b+, CD11c+ | CD11clo, CD1ahi, Langerin+ | Id2, Runx3 | Dermal and epidermal antigen presentation IL-23, IL-6, IL-1β |
Th17 response |